Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
O. Lukkarinen & M. Kontturi. (1994) Comparison of a Long-Acting LHRH Agonist and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Carcinoma. Scandinavian Journal of Urology and Nephrology 28:2, pages 171-178.
Read now
Read now
K. Sjövall, S. Rubin & J. Müntzing. (1975) Creatine Phosphokinase in Prostatic Tissue. Scandinavian Journal of Urology and Nephrology 9:3, pages 181-184.
Read now
Read now
Curt Franksson & Lars G. Collste. (1974) Prostato-Vesiculectomy in 20 Patients with Malignant Prostatic Tumour. Scandinavian Journal of Urology and Nephrology 8:3, pages 162-166.
Read now
Read now
J. Müntzirig, T. Nilsson & J. Polacek. (1974) Zinc and β-Glucuronidase in the Human Prostate. Scandinavian Journal of Urology and Nephrology 8:2, pages 87-90.
Read now
Read now
Torgny Nilsson & Jonas Müntzing. (1973) Histochemical and Biochemical Enzyme Studies in Prostatic Carcinomatous Tissue Before and During Treatment with Estrogen. Scandinavian Journal of Urology and Nephrology 7:1, pages 14-17.
Read now
Read now
Gösta Jönsson & Bertil Högberg. (1971) Treatment of Advanced Prostatic Carcinoma with Estracyt: A Preliminary Report. Scandinavian Journal of Urology and Nephrology 5:2, pages 103-107.
Read now
Read now
Articles from other publishers (19)
Arto Mikkola, Jussi Aro, Sakari Rannikko & Mirja Ruutu. (2007) Ten-year survival and cardiovascular mortality in patients with advanced prostate cancer primarily treated by intramuscular polyestradiol phosphate or orchiectomy. The Prostate 67:4, pages 447-455.
Crossref
Crossref
Mikkola, Ruutu, Aro, Rannikko & Salo on behalf of the Finnprostate Group. (2008) Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2‐year follow‐up report of a national, prospective prostatic cancer study. British Journal of Urology 82:1, pages 63-68.
Crossref
Crossref
Jan-Erik Johansson, Swen-Olof Andersson, Lars Holmberg & Reinhold Bergstrom. (1991) Primary Orchiectomy Versus Estrogen Therapy in Advanced Prostatic Cancer—A Randomized Study: Results After 7 to 10 Years of Followup. Journal of Urology 145:3, pages 519-522.
Crossref
Crossref
R. HAAPIAINEN, S. RANNIKKO, M. RUUTU, M. ALA-OPAS, E. HANSSON, H. JUUSELA, J. PERMI, M. SAARIALHO, J. VIITANEN & O. ALFTHAN. (1991) Orchiectomy versus Oestrogen in the Treatment of Advanced Prostatic Cancer. British Journal of Urology 67:2, pages 184-187.
Crossref
Crossref
Peter Ekman. 1991. The Medical Management of Prostate Cancer II. The Medical Management of Prostate Cancer II
45
52
.
J. Aro. (2006) Cardiovascular and all‐cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population. The Prostate 18:2, pages 131-137.
Crossref
Crossref
R. HAAPIAINEN, S. RANNIKKO & O. ALFTHAN. (1990) Comparison of Primary Orchiectomy and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Cancer. British Journal of Urology 66:1, pages 94-97.
Crossref
Crossref
J. L. V. ARO, R. K. HAAPIAINEN, S. A. S. RANNIKKO & O. S. ALFTHAN. (1989) High Dose Polyoestradiol Phosphate with and without Acetosalicylic Acid versus Orchiectomy in the Treatment of Prostatic Cancer. British Journal of Urology 63:5, pages 512-514.
Crossref
Crossref
R. HAAPIAINEN, S. RANNIKKO & O. ALFTHAN. (2008) Comparison of Primary Orchiectomy with Oestrogen Therapy in Advanced Prostatic Cancer; A 2‐Year Follow‐up Report of a National, Prospective Prostatic Cancer Study. British Journal of Urology 58:5, pages 528-533.
Crossref
Crossref
I. Könyves & L. Andersson. (2006) International overview on the treatment of prostate cancer–scandinavian experience. The Prostate 5:4, pages 383-386.
Crossref
Crossref
Svein A. Haukaas & Terje Kalland. (2006) Effect of diethylstilbestrol and estramustine phosphate (estracyt®) on delayed hypersensitivity response to oxazolone in male mice. The Prostate 3:2, pages 149-157.
Crossref
Crossref
S. B. Andersson, P. O. Gunnarsson, T. Nilsson & G. Plym Forshell. (1981) Metabolism of estramustine phosphate (Estracyt ®) in patients with prostatic carcinoma. European Journal of Drug Metabolism and Pharmacokinetics 6:2, pages 149-154.
Crossref
Crossref
Peter Ekman, Marek Snochowski, Anders Zetterberg, Bertil Högberg & Jan-Åke Gustafsson. (1979) Steroid receptor content in human prostatic carcinoma and response to endocrine therapy. Cancer 44:4, pages 1173-1181.
Crossref
Crossref
H. TRASTI, S. NILSSON & L.-E. PETERSON. (1979) Applied Diagnostic Techniques: A Decisive Factor in the Long-term T-year Survival Rate in Prostatic Carcinoma. British Journal of Urology 51:2, pages 135-139.
Crossref
Crossref
G. Jönsson, A.M. Olsson, W. Luttrop, Z. Cekan, K. Purvis & E. Diczfalusy. 1976.
351
376
.
Martin I. Resnick & John T. Grayhack. (1975) Treatment of Stage IV Carcinoma of the Prostate. Urologic Clinics of North America 2:1, pages 141-161.
Crossref
Crossref
G. Lunglmayr, J. Spona & M. Pecherstorfer. (1974) Zur Frage der Orchidektomie beim Prostatakarzinom. European Surgery 6:3, pages 62-67.
Crossref
Crossref
H.-K. BüscherM. Hohbach. 1973. 24. Tagung vom 13. bis 16. September 1972 in Hannover. 24. Tagung vom 13. bis 16. September 1972 in Hannover
311
316
.
J. M�ntzing & T. Nilsson. (1972) Lipofuscin in malignant and non-malignant human prostatic tissue. Zeitschrift f�r Krebsforschung und Klinische Onkologie 77:2, pages 166-170.
Crossref
Crossref